
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Lilly Asian Ventures is an investment firm that invests in promising life science companies.
Investor Profile
Lilly Asia Ventures has made 119 investments, with 11 in the past 12 months and 18% as lead.
Stage Focus
- Series A (31%)
- Series B (29%)
- Series C (20%)
- Series Unknown (5%)
- Series E (4%)
- Series D (3%)
- Post Ipo Equity (2%)
- Private Equity (2%)
- Seed (2%)
- Convertible Note (1%)
Country Focus
- China (50%)
- United States (46%)
- Hong Kong (2%)
- Israel (1%)
- South Korea (1%)
- United Kingdom (1%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Therapeutics
- Biopharma
- Medical Device
- Life Science
- Oncology
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.